Trump Imposes 100% Tariff on Imported Brand-Name Drugs
On 2 April 2026 President Trump signed a Section 232 order slapping a 100 % duty on patented pharmaceuticals made abroad, with lower interim rates for firms that on-shore production or cut U.S. prices, effective within 120–180 days.